Linked Life Data

3120734

Source:http://linkedlifedata.com/resource/pubmed/id/3120734

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3120734rdf:typepubmed:Citationlld:pubmed
pubmed-article:3120734lifeskim:mentionsumls-concept:C0085979lld:lifeskim
pubmed-article:3120734lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:3120734lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:3120734lifeskim:mentionsumls-concept:C0026336lld:lifeskim
pubmed-article:3120734lifeskim:mentionsumls-concept:C0023884lld:lifeskim
pubmed-article:3120734lifeskim:mentionsumls-concept:C1383501lld:lifeskim
pubmed-article:3120734lifeskim:mentionsumls-concept:C0085180lld:lifeskim
pubmed-article:3120734lifeskim:mentionsumls-concept:C1160466lld:lifeskim
pubmed-article:3120734lifeskim:mentionsumls-concept:C0034917lld:lifeskim
pubmed-article:3120734lifeskim:mentionsumls-concept:C1710236lld:lifeskim
pubmed-article:3120734pubmed:issue24lld:pubmed
pubmed-article:3120734pubmed:dateCreated1988-1-21lld:pubmed
pubmed-article:3120734pubmed:abstractTextGlutathione-S-transferase (GST) activity has been examined in liver cytosol fractions from guinea pigs, mice, control fed rats or rats with pre-neoplastic nodular liver lesions. The levels of activity in unfractionated cytosols have been assayed using the model substrates 1-chloro-2,4-dinitrobenzene (CDNB), 3,4-dichloronitrobenzene (DCNB) and monobromobimane (mBrB) with reduced glutathione (GSH). The order of activities in the various liver fractions using CDNB as substrate were: mouse greater than pre-neoplastic nodular rat greater than guinea pig greater than control rat and paralleled the capacities of the cytosols to catalyse the formation of aflatoxin B1-GSH from microsomally-activated aflatoxin B1 (AFB1) and GSH. Quantitative differences between the activities of the cytosols using the three model substrates were observed. In the mouse fractionation of GST activity by isoelectric focusing (I.E.F.) on preparative granular gels showed that the most basic component (isoelectric point pH 9.4) with the highest conjugating activity with respect to microsomally-activated AFB1 did not correspond with the peak of most activity for conjugating CDNB. In the pre-neoplastic nodular rat liver the CDNB conjugating activities of all fractions separated on granular I.E.F. gels, were higher than the corresponding fractions isolated from control rat liver, with particular enhancement of the peak containing the 3:3 isoenzyme. In contrast to control rat liver the 7:7 isoenzyme was detected in pre-neoplastic nodular liver preparations. These isoenzymes (3:3 and 7:7) did not contribute significantly to the enhanced level of AFB1-GSH formation catalysed by cytosol fractions prepared from pre-neoplastic nodular rat liver. The microsomally-activated AFB1-conjugating activity of unfractionated rat liver cytosols was increased to a relatively greater extent than CDNB conjugating activity during the induction of pre-neoplastic nodular liver lesions, and the elevated level of the activated AFB1-conjugating activity was found to be associated with the most basic fraction (isoelectric point pH 9.0). Analytical isoelectric focusing gels using mBrB as substrate demonstrated the presence of a basic GST isoenzyme in the pre-neoplastic nodular rat liver, not detected in preparations from the livers of control rats. The low level of activated AFB1-conjugating activity present in unfractionated guinea-pig cytosol was found to correspond with the fraction containing the peak of CDNB conjugating activity on preparative isoelectric focusing (isoelectric point pH 7.5). The lack of correlation between the conjugation of model substrates and the conjugation of xenobiotics could be of importlld:pubmed
pubmed-article:3120734pubmed:languageenglld:pubmed
pubmed-article:3120734pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3120734pubmed:citationSubsetIMlld:pubmed
pubmed-article:3120734pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3120734pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3120734pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3120734pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3120734pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3120734pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3120734pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3120734pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3120734pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3120734pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3120734pubmed:statusMEDLINElld:pubmed
pubmed-article:3120734pubmed:monthDeclld:pubmed
pubmed-article:3120734pubmed:issn0006-2952lld:pubmed
pubmed-article:3120734pubmed:authorpubmed-author:HulbertP BPBlld:pubmed
pubmed-article:3120734pubmed:authorpubmed-author:NealG EGElld:pubmed
pubmed-article:3120734pubmed:authorpubmed-author:JudahD JDJlld:pubmed
pubmed-article:3120734pubmed:authorpubmed-author:NielschUUlld:pubmed
pubmed-article:3120734pubmed:issnTypePrintlld:pubmed
pubmed-article:3120734pubmed:day15lld:pubmed
pubmed-article:3120734pubmed:volume36lld:pubmed
pubmed-article:3120734pubmed:ownerNLMlld:pubmed
pubmed-article:3120734pubmed:authorsCompleteYlld:pubmed
pubmed-article:3120734pubmed:pagination4269-76lld:pubmed
pubmed-article:3120734pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:3120734pubmed:meshHeadingpubmed-meshheading:3120734-...lld:pubmed
pubmed-article:3120734pubmed:meshHeadingpubmed-meshheading:3120734-...lld:pubmed
pubmed-article:3120734pubmed:meshHeadingpubmed-meshheading:3120734-...lld:pubmed
pubmed-article:3120734pubmed:meshHeadingpubmed-meshheading:3120734-...lld:pubmed
pubmed-article:3120734pubmed:meshHeadingpubmed-meshheading:3120734-...lld:pubmed
pubmed-article:3120734pubmed:meshHeadingpubmed-meshheading:3120734-...lld:pubmed
pubmed-article:3120734pubmed:meshHeadingpubmed-meshheading:3120734-...lld:pubmed
pubmed-article:3120734pubmed:meshHeadingpubmed-meshheading:3120734-...lld:pubmed
pubmed-article:3120734pubmed:meshHeadingpubmed-meshheading:3120734-...lld:pubmed
pubmed-article:3120734pubmed:meshHeadingpubmed-meshheading:3120734-...lld:pubmed
pubmed-article:3120734pubmed:meshHeadingpubmed-meshheading:3120734-...lld:pubmed
pubmed-article:3120734pubmed:meshHeadingpubmed-meshheading:3120734-...lld:pubmed
pubmed-article:3120734pubmed:meshHeadingpubmed-meshheading:3120734-...lld:pubmed
pubmed-article:3120734pubmed:meshHeadingpubmed-meshheading:3120734-...lld:pubmed
pubmed-article:3120734pubmed:meshHeadingpubmed-meshheading:3120734-...lld:pubmed
pubmed-article:3120734pubmed:meshHeadingpubmed-meshheading:3120734-...lld:pubmed
pubmed-article:3120734pubmed:meshHeadingpubmed-meshheading:3120734-...lld:pubmed
pubmed-article:3120734pubmed:meshHeadingpubmed-meshheading:3120734-...lld:pubmed
pubmed-article:3120734pubmed:year1987lld:pubmed
pubmed-article:3120734pubmed:articleTitleConjugation of model substrates or microsomally-activated aflatoxin B1 with reduced glutathione, catalysed by cytosolic glutathione-S-transferases in livers of rats, mice and guinea pigs.lld:pubmed
pubmed-article:3120734pubmed:affiliationToxicology Unit, M.R.C. Laboratories, Carshalton, Surrey, U.K.lld:pubmed
pubmed-article:3120734pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3120734lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3120734lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3120734lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3120734lld:pubmed